The ingestion of non-steroidal anti-inflammatory drugs (NSAID) in 272 patients with bleeding or perforated peptic ulcer was compared with 272 age/sex matched controls. A significantly higher proportion of patients with gastric ulcers had received NSAID than those with duodenal ulcers.
Introduction
Non-steroidal anti-inflammatory drugs (NSAID) are very effective in the treatment of arthritis but their use is associated with significant morbidity and mortality from the complications of peptic ulceration.'-7 The prevalence of peptic ulceration in patients receiving NSAID lies between 17% and 31%.8'-' It has been suggested that elderly patients receiving NSAID are the most likely to develop the complications of peptic ulceration.4'7"2 The incidence of perforated peptic ulcer is increasing in the elderly'2 with the number decreasing in men and increasing in women. 1 The use of NSAID has been suggested as the prime reason for this4-6 "'2 but other factors such as cigarette smoking'3 may also be important. It is reported that NSAID can also modify the symptoms of the ulcer, which may result in diagnostic delay and a poorer prognosis.'4 The association of NSAID with the complications of duodenal ulceration has been harder to prove than that with gastric ulceration.
This study was performed to investigate the relationship between NSAID ingestion in patients above and below 65 years admitted with bleeding or perforated peptic ulcers. We also wanted to compare the prevalence of NSAID ingestion in patients with complicated gastric and duodenal ulcers. The data was divided into patients under and over 65 years (Table II) . Below the age of 65 there was no significant difference in NSAID ingestion between patients with peptic ulcers and controls. In patients above 65, however, there were significant differences for bleeding duodenal ulcer (P = 0.004), perforated gastric ulcer (P = 0.004), perforated duodenal ulcer (P = 0.03) and bleeding gastric ulcer (P = 0.012).
Methods
Fourteen of 27 (51.8%) of the combined bleeding and perforated gastric ulcer group, over 65, had received NSAID compared with 16 of 53 (30%) of the equivalent duodenal ulcer patients (P = 0.058, x2 test). Table III shows the relative risks of NSAID ingestion in patients with ulcers compared with controls. The relative risks were higher in the > 65 year old age group than in the < 65 year old group in both bleeding and perforated ulcers. Two patients were receiving aspirin and NSAID and one patient was receiving NSAID and steroids.
Discussion
In this study NSAID ingestion was more prevalent in patients with the complications of gastric, rather than duodenal ulcers. This may explain why it has been more difficult to prove the association of NSAID with the complications of duodenal ulceration in the past. The data in this study was from retrospective note review and there are biases inhercnt in using such a method. We probably underestimated the number of controls and study patients taking NSAID. There is also bias from the observer and from the recorded history with most doctors making a more thorough drug enquiry in patients with a bleeding or perforated peptic ulcer. Retrospective note review is inaccurate in assessing the intake of non-prescribed drugs. These factors would not, however, explain the differences found in the >65 year old group or the stronger association with gastric ulcer.
This study confirms the danger of NSAID ingestion to patients of over 65 years and highlights the particular susceptibility of the gastric mucosa to their injurious effect. Particular care must be taken with these drugs which may modify the symptoms of the ulcer they produce, especially now they are becoming more readily available to the general public.
